InsidersTradesSigma
Browse the detailed record of transactions filed by Rolf Ingvar Lennart Karlsson, Chief Financial Officer. Director active across 2 companies, notably Elicera Therapeutics AB. Cumulatively, 1 reports have been published. History available since 10 March 2025. The latest transaction was disclosed on 10 March 2025 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Rolf Ingvar Lennart Karlsson is the Chief Financial Officer of Elicera Therapeutics AB. He oversees the company's financial operations, ensuring effective resource management and compliance with financial regulations. His role is essential for the organization's financial strategy.